Listed

Reflect Scientific, Inc.: Form 10-Q for the period ended Mar 31, 2015

Filed with the SEC on May 15, 2015 and accepted by EDGAR at May 14, 2015, 18:14 ET.

Share

Management's discussion and analysis

As filed, 8,726 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Special Note Regarding Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 (the “Act”) provides a safe harbor for forward-looking statements made by or on behalf of our Company. Our Company and our representatives may from time to time make written or oral statements that are “forward-looking,” including statements contained in this Annual Report and other filings with the Securities and Exchange Commission and in reports to our Company’s stockholders. Management believes that all statements that express expectations and projections with respect to future matters, as well as from developments beyond our Company’s control including changes in global economic conditions are forward-looking statements within the meaning of the Act. These statements are made on the basis of management’s views and assumptions, as of the time the statements are made, regarding future events and business performance. There can be no assurance, however, that management’s expectations will necessarily come to pass. Factors that may affect forward- looking statements include a wide range of factors that could materially affect future developments and performance, including the following:

Changes in Company-wide strategies, which may result in changes in the types or mix of businesses in which our Company is involved or chooses to invest;

Changes in U.S., global or regional economic conditions;

Changes in U.S. and global financial and equity markets, including significant interest rate fluctuations, which may impede our Company’s access to, or increase the cost of, external financing for our operations and investments;

Increased competitive pressures, both domestically and internationally;

Legal and regulatory developments, such as regulatory actions affecting environmental activities;

The imposition by foreign countries of trade restrictions and changes in international tax laws or currency controls;

Adverse weather conditions or natural disasters, such as hurricanes and earthquakes, labor disputes, which may lead to increased costs or disruption of operations.

This list of factors that may affect future performance and the accuracy of forward-looking statements are illustrative, but by no means exhaustive. Accordingly, all forward-looking statements should be evaluated with the understanding of their inherent uncertainty.

Critical Accounting Policies and Estimates

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the unaudited Financial Statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results could differ from these estimates under different assumptions or conditions. The Company believes there have been no significant changes during the three month period ended March 31, 2015, to the items disclosed as significant accounting policies in management's Notes to the Financial Statements in the Company's Annual Report on Form 10-K for the year ended December 31, 2014.

Plan of Operation and Business Growth

We continue to be focus on increasing the sales of our life science consumables and detectors while also working to commercialize our ultra-low temperature liquid nitrogen refrigeration products. Of those liquid nitrogen refrigeration products, the refrigerated trailer, known as a “reefer”, is receiving highest priority. We continue to test, gather and analyze data generated from road tests of our first manufactured unit to validate its efficiency and reliability. We have also developed alliances with contract manufacturers for our ultra-low temperature freezers.

We continue to develop the market visibility of our detector. We believe that the enhanced functionality of our detector, coupled with its low cost, provides us with a competitive edge over products currently being sold in that specialized market.

Concurrent with the development and commercialization of the above products, we are working to expand sales of our specialty laboratory supplies and detectors through widening our catalog distribution, our on-line order site, and the addition of new distributors

Our revenues during the reporting period decreased 22% during 2015 compared to 2014 revenues.

Results of Operations

Three Months Ended March 31, 2015 and 2014

For the three months ended March 31, 2015 2014 Change
Revenues $313,222 $402,442 $(89,220)
Cost of goods sold 121,317 163,783 (42,466)
Gross profit 191,905 238,659 (46,754)
Operating expenses 193,627 181,482 12,145
Other income (expense) (29,552) (31,083) 1,531
Net Income (loss) $(31,275) $26,094 $(57,371)

Revenues decreased during the quarter ended March 31, 2015, to $313,222 from $402,442 for the quarter ended March 31, 2014, a decrease of $89,220. The revenues were generated primarily from our specialized laboratory supplies and detector sales, with $29,150 coming from the sale of an ultra-low temperature freezer. We are continuing to refine and commercialize the ultra-low temperature freezer technology.

With decreased sales during the reporting period, cost of goods sold decreased in the quarter ending March 31, 2015, as compared to March 31, 2014 to $121,317 from $163,783, a decrease of $42,466. The gross profit percentage improved to 61% for the three months ended March 31, 2015, compared to 59% for the three months ended March 31, 2014. The increase in gross profit percentage relates primarily to the mix of product sales, with much of the revenue increase during the reporting period coming from the products which carry higher profit margins. In addition, we continue to actively work to obtain more favorable pricing from our vendors in order to increase the margins realized on our product lines.

Operating expenses for the three months ended March 31, 2015 were $193,627, which represents an increase of $12,145 from the $181,482 in operating expenses recorded for the three month period ended March 31, 2014. The increase results primarily from higher insurance costs, salaries, and professional fees. Operating expenses for the remaining reporting periods in 2015 are expected to remain near the levels shown for the period of this report.

The net loss for the three month period ended March 31, 2015 was $31,275, a decline of $57,371from the $26,094 net profit for the three month period ended March 31, 2014. The change results from the lower sales levels, combined with increased operating expenses. Increased operating expenses have resulted from additional work to accelerate the commercialization of the ultra-low temperature freezer and reefer.

The net profit for the three months ended March 31, 2015 was $0.00 per share on both a basic and fully diluted basis. The net loss for the three months ended March 31, 2014 was also $0.00 per share.

Seasonality and Cyclicality

We do not believe our business is cyclical.

Liquidity and Capital Resources

Our cash resources at March 31, 2015, were $364,533, with net accounts receivable of $124,734 and net inventory of $214,697. To date we have relied on revenues and sales of equity and debt securities for our cash resources. Our working capital deficit on March 31, 2015, was $686,573, due primarily to the $650,000 in outstanding debentures and $676,125 in accrued interest on those debentures. Working capital on December 31, 2014 was a deficit of $663,672. Management is working to obtain financing to enable it to retire the remaining outstanding debentures and provide the capital needed to commercialize the low temperature freezer and refrigeration technology. There can be no assurance that funds will be available, or that terms of available funds will be acceptable to the Company. The inability of the Company to obtain funding at acceptable terms could negatively impact its ability to execute its business plan.

For the three month period ended March 31, 2015, net cash provided from operating activities was $96,177 which compares to $77,895 of net cash used for operating activities for the three month period ended March 31, 2014.

Off-Balance Sheet Arrangements

We lease office and warehouse space under a non-cancelable operating lease in Utah. Future minimum lease payments under the operating lease at March 31, 2015 are $99,200 for that facility. In addition, we have automobile leases with future minimum lease payments of $17,472.

Market risk

As filed, 341 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

At March 31, 2015, the remaining outstanding convertible debentures in default were $650,000, including penalties. The debentures bear an 18% interest rate. The Company accrued an additional $29,250 in interest during the quarter ended March 31, 2015. The total accrued interest on this remaining debenture was $676,125 as of March 31, 2015.

Controls and procedures

As filed, 2,159 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

(a)

Management’s Report on Internal Control Over Financial Reporting.

As of the end of the period covered by this Quarterly Report, we carried out an evaluation, under the supervision and with the participation of our Chief Executive Officer and Principal Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon this evaluation, our Chief Executive Officer and Principal Financial Officer concluded that information required to be disclosed is recorded, processed, summarized and reported within the specified periods, and is accumulated and communicated to management, including our Chief Executive Officer and

Principal Financial Officer, to allow for timely decisions regarding required disclosure of material information required to be included in our periodic Securities and Exchange Commission reports. During the fourth quarter of 2014 we incorrectly valued an equity transaction; a stock value other than the closing price of the stock on the date of the stock grant. During the three months ended March 31, 2015 we have been implementing enhanced documentation, review and supervision processes and procedures the valuation of equity transactions. We believe that those changes are now fully implemented, and that such implementation will provide reasonable assurance that the valuation of equity transactions is being properly monitored, and that those revised and implemented disclosure controls and procedures are effective to a reasonable assurance level of achieving such objectives. However, it should be noted that the design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote.

(b)

Changes in Internal Control Over Financial Reporting.

The implementation of processes and procedures to insure the proper valuation of equity transactions to enhance our internal control over financial reporting was made during the period covered by this Quarterly Report.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2015-01-01 to 2015-03-31$313.2kus-gaap:Revenues
Cost of revenue3 months2015-01-01 to 2015-03-31$121.3kus-gaap:CostOfGoodsSold
Gross profit3 months2015-01-01 to 2015-03-31$191.9kus-gaap:GrossProfit
Research and development3 months2015-01-01 to 2015-03-31$5.2kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2015-01-01 to 2015-03-31−$1.7kus-gaap:OperatingIncomeLoss
Interest expense3 months2015-01-01 to 2015-03-31−$303us-gaap:InterestExpense
Income tax3 months2015-01-01 to 2015-03-31$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2015-01-01 to 2015-03-31−$31.3kus-gaap:NetIncomeLoss
Diluted EPS3 months2015-01-01 to 2015-03-31$0.00us-gaap:EarningsPerShareBasicAndDiluted
Cash and equivalentsAt period end2015-03-31$364.5kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2015-03-31$707.1kus-gaap:AssetsCurrent
Total assetsAt period end2015-03-31$795.8kus-gaap:Assets
Current liabilitiesAt period end2015-03-31$1.4mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2015-03-31$1.4mus-gaap:Liabilities
Shareholders' equityAt period end2015-03-31−$597.8kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001548123-15-000178. Last ingested by Listed: Oct 24, 2026, 15:01 ET. Listed shows no prices and gives no investment advice.